Conversely, p53 represses the E2 ubiquitin-conjugating enzyme Ube2c [106], and its inhibition sensitizes breast cancer cells to the DNA damaging effects of doxorubicin [107]. The gene discussed is TP53; the disease is breast carcinoma.